icon-folder.gif   Conference Reports for NATAP  
  HIV Glasgow 2022
23-26 October
Virtual Meeting
Back grey_arrow_rt.gif
Real World Utilisation of Doravirine
Among People Living With HIV in England (DRIVE-REAL)

  HIV Glasgow, Glasgow, 23-26th October 2022
Merck to Initiate New Phase 3 Clinical Program with Lower Dose of Daily Oral Islatravir in Combination with Doravirine for Treatment of People with HIV-1 Infection - (09/20/22)
Charlotte O'Halloran1; Yvonne Gilleece2; Suki Leung3; Veronica Canuto3; Connor McAlpine4; Sophie Ross2; Claire Norcross2; Stuart Gaffney1; Nipur Siani1; William Hickey1; Adam Moore5; Olivera Rajkovic-Hooley5; Ana Milinkovic4
1 Medical Affairs (HIV), MSD (UK) Limited, London, UK; 2 Brighton & Sussex Medical School and University Hospitals Sussex NHS Trust, HIV and Sexual Health, Brighton, UK; 3 Chelsea and Westminster Hospital NHS Foundation Trust, St Stephen's Centre, London, UK; 4 Centre for Clinical Research in Infection and Sexual Health, University College London and Mortimer Market Centre(MMC), London, UK; 5 Adelphi, Real World (ARW), Bollington, UK
Contact: charlotte.ohalloran"at"msd.com for questions and comments